Scott Kogan, MD

Title(s)Professor, Laboratory Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, MSB, #561A
San Francisco CA 94117
Phone415-514-0815
ORCID ORCID Icon0000-0002-2395-8479 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, CAM.D.1991 School of Medicine
    University of California, San Francisco, CA Residency 1994School of Medicine
    University of California, San Francisco, CA10/2020Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Impact of low IL-10 levels at birth and leukemia risk
    NIH R01CA185058Jun 1, 2014 - May 31, 2020
    Role: Co-Principal Investigator
    Impact of B-Cell Lineage on Progression of B-Acute Lymphoblastic Leukemia
    NIH R21CA173028Feb 1, 2013 - Jan 31, 2016
    Role: Co-Principal Investigator
    Center for Integrative Research on Childhood Leukemia and the Environment
    NIH P50ES018172Sep 25, 2009 - Jun 30, 2019
    Role: Co-Investigator
    Molecular Mechanisms of Leukemogenesis by PMLRAR alpha
    NIH R01CA095274Apr 1, 2002 - Jan 31, 2014
    Role: Principal Investigator
    PATHOGENESIS AND THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA
    NIH K08CA075986Feb 19, 1999 - Jan 31, 2004
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia. Haematologica. 2023 Dec 28. Wintering A, Hecht A, Meyer J, Wong EB, Hübner J, Abelson S, Feldman K, Kennedy VE, Peretz CAC, French DL, Maguire JA, Jobaliya C, Vasquez MR, Desai S, Dulman R, Nemecek E, Haines H, Hammad M, El Haddad A, Kogan SC, Abdullaev Z, Chehab FF, Tasian SK, Smith CC, Loh ML, Stieglitz E. PMID: 38152053.
      View in: PubMed   Mentions:    Fields:    
    2. Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of ETV6::RUNX1. Haematologica. 2023 Dec 01; 108(12):3480-3484. Fitch BA, Situ J, Wiemels JL, Wiemels JL, Kogan SC, Zhou M. PMID: 37345483; PMCID: PMC10690896.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    3. Gene-Environment Analyses Reveal Novel Genetic Candidates with Prenatal Tobacco Exposure in Relation to Risk for Childhood Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2023 12 01; 32(12):1707-1715. Zhong C, Li S, Arroyo K, Morimoto LM, de Smith AJ, Metayer C, Ma X, Kogan SC, Gauderman WJ, Wiemels JL, Wiemels JL. PMID: 37773025.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    4. Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group. Blood. 2023 Nov 28; 142(Supplement 1):74. Stieglitz SE, Lee LA, Angus AS, Davis DC, Barkauskas BD, Hall HD, Kogan KS, Meyer MJ, Rhodes RS, Xuei XX, Shannon SK, Loh LM, Fox FE, Weigel WB. .
      View in: Publisher Site   Mentions:
    5. Genetic architecture of the acute and persistent immune cell response after radiation exposure. Cell Genom. 2023 Nov 08; 3(11):100422. He L, Zhong C, Chang H, Inman JL, Celniker SE, Ioakeim-Ioannidou M, Liu KX, Haas-Kogan D, MacDonald SM, Threadgill DW, Kogan SC, Mao JH, Snijders AM. PMID: 38020972; PMCID: PMC10667298.
      View in: PubMed   Mentions:
    6. The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression. J Clin Invest. 2023 07 03; 133(13). Mas G, Man N, Nakata Y, Martinez-Caja C, Karl D, Beckedorff F, Tamiro F, Chen C, Duffort S, Itonaga H, Mookhtiar AK, Kunkalla K, Valencia AM, Collings CK, Kadoch C, Vega F, Kogan SC, Shiekhattar R, Morey L, Bilbao D, Nimer SD. PMID: 37200093; PMCID: PMC10313367.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    7. Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. Hematology. 2022 Dec; 27(1):1253-1258. Hu Y, Geere M, Awan M, Leavitt AD, Brown LE, Pearson HJ, Gandelman JS, Kogan SC. PMID: 36444994; PMCID: PMC9788447.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children. Haematologica. 2022 09 01; 107(9):2266-2270. Wiemels JL, Wiemels JL, Wang R, Zhou M, Hansen H, Gallant R, Jung J, Mancuso N, De Smith AJ, Metayer C, Kogan SC, Ma X. PMID: 35638549; PMCID: PMC9425315.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature. 2022 09; 609(7925):174-182. Carnevale J, Shifrut E, Kale N, Nyberg WA, Blaeschke F, Chen YY, Li Z, Bapat SP, Diolaiti ME, O'Leary P, Vedova S, Belk J, Daniel B, Roth TL, Bachl S, Anido AA, Prinzing B, Ibañez-Vega J, Lange S, Haydar D, Luetke-Eversloh M, Born-Bony M, Hegde B, Kogan S, Feuchtinger T, Okada H, Satpathy AT, Shannon K, Gottschalk S, Eyquem J, Krenciute G, Ashworth A, Marson A. PMID: 36002574; PMCID: PMC9433322.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    10. Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia. Cytogenet Genome Res. 2022; 162(3):119-123. Qi Z, Wen KW, Ki A, Prakash S, Kogan S, Yu J. PMID: 35675801; PMCID: PMC9677869.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation. JACC Adv. 2022 Jun; 1(2). Thomas A, Fang MC, Kogan S, Hubbard CC, Friedman PN, Gong L, Klein TE, Nutescu EA, O'Brien TJ, Tuck M, Perera MA, Schwartz JB. PMID: 37961076; PMCID: PMC10643025.
      View in: PubMed   Mentions:
    12. Clinical characteristics of cytomegalovirus-positive pediatric acute lymphoblastic leukemia at diagnosis. Am J Hematol. 2022 06 01; 97(6):E198-E201. Gallant RE, Arroyo K, Bracci PM, Li S, Metayer C, Kogan SC, Wendt GA, Francis SS, de Smith AJ, Wiemels JL, Wiemels JL. PMID: 35285969.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    13. Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. Blood Adv. 2022 01 08; 6(3):854-865. Fitch BA, Zhou M, Situ J, Surianarayanan S, Reeves MQ, Hermiston ML, Wiemels JL, Wiemels JL, Kogan SC. PMID: 34727170; PMCID: PMC8945291.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    14. Preventing Bleeding With Direct-Acting Oral Anticoagulants. J Am Coll Cardiol. 2021 10 19; 78(16):e127. Schwartz JB, Kogan SC, Fang MC. PMID: 34649705; PMCID: PMC10631742.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Blood Adv. 2021 09 28; 5(18):3587-3591. Morales CE, Stieglitz E, Kogan SC, Loh ML, Braun BS. PMID: 34464969; PMCID: PMC8945579.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    16. Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1526-1535. Whitehead TP, Wiemels JL, Wiemels JL, Zhou M, Kang AY, McCoy LS, Wang R, Fitch B, Petrick LM, Yano Y, Imani P, Rappaport SM, Dahl GV, Kogan SC, Ma X, Metayer C. PMID: 34078642; PMCID: PMC8338848.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    17. Epigenetic Biomarkers of Prenatal Tobacco Smoke Exposure Are Associated with Gene Deletions in Childhood Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1517-1525. Xu K, Li S, Whitehead TP, Pandey P, Kang AY, Morimoto LM, Kogan SC, Metayer C, Wiemels JL, Wiemels JL, de Smith AJ. PMID: 34020997; PMCID: PMC8338876.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    18. Anti-factor Xa activity assays of direct-acting oral anticoagulants during clinical care: An observational study. Res Pract Thromb Haemost. 2021 May; 5(4):e12528. Sukumar S, Cabero M, Tiu S, Fang MC, Kogan SC, Schwartz JB. PMID: 34013157; PMCID: PMC8114026.
      View in: PubMed   Mentions: 1  
    19. In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system. Clin Sci (Lond). 2021 04 30; 135(8):1053-1063. Snijders AM, Zhou M, Whitehead TP, Fitch B, Pandey P, Hechmer A, Huang A, Schick SF, de Smith AJ, Olshen AB, Metayer C, Mao JH, Wiemels JL, Wiemels JL, Kogan SC. PMID: 33851706; PMCID: PMC8086195.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsPHPublic Health
    20. Trends in Acute Lymphoblastic Leukemia Incidence in the United States by Race/Ethnicity From 2000 to 2016. Am J Epidemiol. 2021 04 06; 190(4):519-527. Feng Q, de Smith AJ, Vergara-Lluri M, Muskens IS, McKean-Cowdin R, Kogan S, Brynes R, Wiemels JL, Wiemels JL. PMID: 33034340.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    21. PML-RARα: changing myeloid networks. Blood. 2021 03 18; 137(11):1439-1440. Kogan SC. PMID: 33734342.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice. JCI Insight. 2020 11 05; 5(21). Wong JC, Perez-Mancera PA, Huang TQ, Kim J, Grego-Bessa J, Del Pilar Alzamora M, Kogan SC, Sharir A, Keefe SH, Morales CE, Schanze D, Castel P, Hirose K, Huang GN, Zenker M, Sheppard D, Klein OD, Tuveson DA, Braun BS, Shannon K. PMID: 32990679; PMCID: PMC7710308.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    23. The Baf Subunit Dpf2 Regulates Resolution of Inflammation By Controlling Macrophage Differentiation Transcription Factor Networks. Blood. 2020 Nov 5; 136(Supplement 1):13-13. Mas Martin MG, Man MN, Karl KD, Martinez MC, Duffort DS, Itonaga IH, Mookhtiar MA, Bilbao BD, Kunkalla KK, Valencia VA, Collings CC, Kadoch KC, Vega VF, Kogan KS, Nimer NS. .
      View in: Publisher Site   Mentions:
    24. History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care System. Am J Epidemiol. 2020 10 01; 189(10):1076-1085. Morimoto LM, Kwan ML, Deosaransingh K, Munneke JR, Kang AY, Quesenberry C, Kogan S, de Smith AJ, Metayer C, Wiemels JL, Wiemels JL. PMID: 32322901; PMCID: PMC7670873.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. Exp Hematol. 2020 10; 90:65-71.e1. Fitch B, Roy R, Geng H, Montecino-Rodriguez E, Bengtsson H, Gaillard C, Hiam K, Casero D, Olshen AB, Dorshkind K, Kogan SC. PMID: 32946981; PMCID: PMC7606616.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    26. Abstract A105: Trends in acute lymphocytic leukemia (ALL) incidence in the US from 2000-2016. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):a105-a105. Feng FQ, Vergara-Lluri VM, Muskens MI, McKean-Cowdin MR, Kogan KS, Brynes BR, de Smith dA, Wiemels WJ. .
      View in: Publisher Site   Mentions:
    27. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. Blood. 2020 05 14; 135(20):1772-1782. Zambetti NA, Firestone AJ, Remsberg JR, Huang BJ, Wong JC, Long AM, Predovic M, Suciu RM, Inguva A, Kogan SC, Haigis KM, Cravatt BF, Shannon K. PMID: 32219446; PMCID: PMC7225687.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    28. Abstract A23: A second site KrasG12D mutation that impairs PI3K binding rescues embryonic lethality, abrogates myeloproliferative disease, and delays lung tumorigenesis. Molecular Cancer Research. 2020 May 1; 18(5_Supplement):a23-a23. Wong WJ, Perez-Mancera PP, Kim KJ, Jen JK, Kogan KS, Firestone FA, Collisson CE, Tuveson TD, Shannon SK. .
      View in: Publisher Site   Mentions:
    29. Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia. Leukemia. 2020 08; 34(8):2025-2037. Wandler AM, Huang BJ, Craig JW, Hayes K, Yan H, Meyer LK, Scacchetti A, Monsalve G, Dail M, Li Q, Wong JC, Weinberg O, Hasserjian RP, Kogan SC, Jonsson P, Yamamoto K, Sampath D, Nakitandwe J, Downing JR, Zhang J, Aster JC, Taylor BS, Shannon K. PMID: 32066867; PMCID: PMC7440098.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    30. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology. Haematologica. 2019 11; 104(11):e514-e516. Nielsen AB, Zhou M, de Smith AJ, Wang R, McCoy L, Hansen H, Morimoto L, Grønbæk K, Johansen C, Kogan SC, Metayer C, Bracci PM, Ma X, Wiemels JL, Wiemels JL. PMID: 30923090; PMCID: PMC6821599.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. Blood. 2019 03 28; 133(13):1495-1506. Esnault C, Rahmé R, Rice KL, Berthier C, Gaillard C, Quentin S, Maubert AL, Kogan S, de Thé H. PMID: 30674471; PMCID: PMC6440296.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    32. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Blood Adv. 2018 10 09; 2(19):2462-2466. Gaillard C, Surianarayanan S, Bentley T, Warr MR, Fitch B, Geng H, Passegué E, de Thé H, Kogan SC. PMID: 30266821; PMCID: PMC6177650.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    33. Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review. Int J Lab Hematol. 2019 Feb; 41(1):80-86. Jacquot C, Wool GD, Kogan SC. PMID: 30194751.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. TCEA1 regulates the proliferative potential of mouse myeloid cells. Exp Cell Res. 2018 09 15; 370(2):551-560. Yang T, Cui H, Wen M, Zuber J, Kogan SC, Wei G. PMID: 30009791; PMCID: PMC6816334.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    35. Abstract 3241: Children with acute lymphoblastic leukemia have increased arginase 2 at birth, implicating immunosuppression in leukemogenesis. Epidemiology. 2018 Jul 1; 3241-3241. Nielsen NA, Zhou ZM, Smith SA, McCoy ML, Hansen HH, Bracci BP, Morimoto ML, Kogan KS, Metayer MC, Ma MX, Wiemels WJ. .
      View in: Publisher Site   Mentions:
    36. Severe Iron Metabolism Defects in Mice With Double Knockout of the Multicopper Ferroxidases Hephaestin and Ceruloplasmin. Cell Mol Gastroenterol Hepatol. 2018; 6(4):405-427. Fuqua BK, Lu Y, Frazer DM, Darshan D, Wilkins SJ, Dunn L, Loguinov AV, Kogan SC, Matak P, Chen H, Dunaief JL, Vulpe CD, Anderson GJ. PMID: 30182051; PMCID: PMC6120670.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    37. Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes. Mol Ther. 2018 07 05; 26(7):1685-1693. An S, Wang X, Ruck MA, Rodriguez HJ, Kostyushev DS, Varga M, Luu E, Derakhshandeh R, Suchkov SV, Kogan SC, Hermiston ML, Springer ML. PMID: 29914756; PMCID: PMC6036225.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    38. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Nat Commun. 2018 05 24; 9(1):2047. Lehmann-Che J, Bally C, Letouzé E, Berthier C, Yuan H, Jollivet F, Ades L, Cassinat B, Hirsch P, Pigneux A, Mozziconacci MJ, Kogan S, Fenaux P, de Thé H. PMID: 29795382; PMCID: PMC5967331.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    39. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. Blood. 2018 02 08; 131(6):636-648. Voisset E, Moravcsik E, Stratford EW, Jaye A, Palgrave CJ, Hills RK, Salomoni P, Kogan SC, Solomon E, Grimwade D. PMID: 29191918; PMCID: PMC5805489.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    40. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? Cancer Genet. 2017 Oct; 216-217:74-78. Foley N, Van Ziffle J, Yu J, Qi Z, Grenert JP, Yeh I, Bastian B, Kogan S, Mannis GN. PMID: 29025598.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    41. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017 03 23; 129(12):1680-1684. Francis SS, Wallace AD, Wendt GA, Li L, Liu F, Riley LW, Kogan S, Walsh KM, de Smith AJ, Dahl GV, Ma X, Delwart E, Metayer C, Wiemels JL, Wiemels JL. PMID: 27979823; PMCID: PMC5364339.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    42. Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression. Blood. 2016 Dec 2; 128(22):753-753. Wandler WA, Huang HB, Scacchetti SA, Craig CJ, Yan YH, Monsalve MG, Li LQ, Dail DM, Wong WJ, Nakitandwe NJ, Weinberg WO, Hasserjian HR, Kogan KS, Sampath SD, Downing DJ, Yamamoto YK, Taylor TB, Aster AJ, Zhang ZJ, Shannon SK. .
      View in: Publisher Site   Mentions:
    43. Mechanism of IL-10 Protective Effect in Development of Childhood B Cell Acute Lymphoblastic Leukemia. Blood. 2016 Dec 2; 128(22):4075-4075. Fitch FB, Hermiston HM, Wiemels WJ, Kogan KS. .
      View in: Publisher Site   Mentions:
    44. Dilute Russell Viper Venom Time Interpretation and Clinical Correlation: A Two-Year Retrospective Institutional Review. Blood. 2016 Dec 2; 128(22):2609-2609. Jacquot JC, Wool WG, Kogan KS. .
      View in: Publisher Site   Mentions:
    45. Identification of IRF8 As a Potent Tumor Suppressor in Murine Acute Promyelocytic Leukemia. Blood. 2016 Dec 2; 128(22):1518-1518. Surianarayanan SS, Gaillard GC, Bentley BT, Warr WM, Fitch FB, Geng GH, Passegue PE, de Thé dH, Kogan KS. .
      View in: Publisher Site   Mentions:
    46. Genetic Subtypes of Human Pediatric ALLs Show Gene Expression Differences That Parallel Those Observed in Mouse B1 and B2 Progenitors, Suggesting Divergent Developmental Origins. Blood. 2016 Dec 2; 128(22):1741-1741. Kogan KS, Geng GH, Roy RR, Montecino-Rodriguez ME, Gaillard GC, Hiam HK, Bengtsson BH, Casero CD, Olshen OA, Dorshkind DK. .
      View in: Publisher Site   Mentions:
    47. Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways. Blood. 2016 Dec 2; 128(22):742-742. Voisset VE, Moravcsik ME, Stratford SE, Jaye JA, Palgrave PC, Hills HR, Salomoni SP, Kogan KS, Solomon SE, Grimwade GD. .
      View in: Publisher Site   Mentions:
    48. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA. Haematologica. 2016 10; 101(10):1228-1236. Keeshan K, Vieugué P, Chaudhury S, Rishi L, Gaillard C, Liang L, Garcia E, Nakamura T, Omidvar N, Kogan SC. PMID: 27390356; PMCID: PMC5046652.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    49. DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia. Cancer Discov. 2016 05; 6(5):501-15. Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick A, Le Beau MM, Kogan S, Salomonis N, Figueroa ME, Grimes HL. PMID: 27016502; PMCID: PMC4861898.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    50. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J Clin Invest. 2016 Jan; 126(1):404. Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K. PMID: 26727232; PMCID: PMC4701564.
      View in: PubMed   Mentions: 2     Fields:    
    51. Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife. 2015 Jul 20; 4. Wong JC, Weinfurtner KM, Alzamora Mdel P, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen SC, Ho TT, Flach J, Reynaud D, Passegué E, Downing JR, Shannon K. PMID: 26193121; PMCID: PMC4569895.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    52. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Haematologica. 2015 Aug; 100(8):1064-75. Gaillard C, Tokuyasu TA, Rosen G, Sotzen J, Vitaliano-Prunier A, Roy R, Passegué E, de Thé H, Figueroa ME, Kogan SC. PMID: 26088929; PMCID: PMC5004423.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    53. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia. Nat Immunol. 2015 Jul; 16(7):766-774. Swaminathan S, Klemm L, Park E, Papaemmanuil E, Ford A, Kweon SM, Trageser D, Hasselfeld B, Henke N, Mooster J, Geng H, Schwarz K, Kogan SC, Casellas R, Schatz DG, Lieber MR, Greaves MF, Müschen M. PMID: 25985233; PMCID: PMC4475638.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansAnimalsCells
    54. Direct and indirect targeting of MYC to treat acute myeloid leukemia. Cancer Chemother Pharmacol. 2015 Jul; 76(1):35-46. Brondfield S, Umesh S, Corella A, Zuber J, Rappaport AR, Gaillard C, Lowe SW, Goga A, Kogan SC. PMID: 25956709; PMCID: PMC4485702.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    55. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet. 2015 May; 47(5):539-43. Zhao Z, Chen CC, Rillahan CD, Shen R, Kitzing T, McNerney ME, Diaz-Flores E, Zuber J, Shannon K, Le Beau MM, Spector MS, Kogan SC, Lowe SW. PMID: 25822087; PMCID: PMC4414804.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    56. Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia. Blood. 2014 Dec 6; 124(21):3753-3753. Burgess BM, Hwang HE, Firestone FA, Huang HT, Xu XJ, Zuber ZJ, Bohin BN, Wen WT, Kogan KS, Haigis HK, Lowe LS, Shannon SK, Li LQ. .
      View in: Publisher Site   Mentions:
    57. Aberrant Hematopoietic Stem Cell Function in Mice Haploinsufficient for a 2 Mb Deletion of Chromosome 5A3 Syntenic to a Region of Human 7q22 Frequently Deleted in Myelodysplastic Syndromes. Blood. 2014 Dec 6; 124(21):3247-3247. Wong WJ, Weinfurtner WK, Alzamora AP, Kogan KS, Burgess BM, Zhang ZY, Nakitandwe NJ, Ma MJ, Cheng CJ, Chen CS, Flach FJ, Reynaud RD, Passegue PE, Downing DJ, Shannon SK. .
      View in: Publisher Site   Mentions:
    58. Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood. 2014 Dec 18; 124(26):3947-55. Burgess MR, Hwang E, Firestone AJ, Huang T, Xu J, Zuber J, Bohin N, Wen T, Kogan SC, Haigis KM, Sampath D, Lowe S, Shannon K, Li Q. PMID: 25361812; PMCID: PMC4271180.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    59. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014 May 12; 25(5):652-65. Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. PMID: 24794707; PMCID: PMC4206212.
      View in: PubMed   Mentions: 172     Fields:    Translation:HumansAnimalsCells
    60. Crenolanib is a selective type I pan-FLT3 inhibitor. Proc Natl Acad Sci U S A. 2014 Apr 08; 111(14):5319-24. Smith CC, Lasater EA, Lin KC, Wang Q, McCreery MQ, Stewart WK, Damon LE, Perl AE, Jeschke GR, Sugita M, Carroll M, Kogan SC, Kuriyan J, Shah NP. PMID: 24623852; PMCID: PMC3986131.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    61. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res. 2014 Jan 15; 74(2):520-31. Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, He X, Wang Q, Huang Y, Jen KY, LaBarge MA, You L, Kogan SC, Gray JW, Mao JH, Wei G. PMID: 24305877; PMCID: PMC3934357.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansAnimalsCells
    62. The Challenge Of Russell’s Viper Venom Time Interpretation For Lupus Anticoagulant Diagnosis: A Two-Year Retrospective Institutional Review. Blood. 2013 Nov 15; 122(21):1131-1131. Wool WG, Kogan KS. .
      View in: Publisher Site   Mentions:
    63. Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia. Blood. 2013 Nov 15; 122(21):3721-3721. Moravcsik ME, Joannides JM, Voisset VE, Stratford SE, Zeisig ZB, Morris MJ, Densham DR, Palgrave PC, Stamp SG, Nye NE, Hills HR, Salomoni SP, Eric So EC, Kogan KS, Solomon SE, Grimwade GD. .
      View in: Publisher Site   Mentions:
    64. Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization. J Exp Med. 2013 Oct 21; 210(11):2337-49. Tesio M, Oser GM, Baccelli I, Blanco-Bose W, Wu H, Göthert JR, Kogan SC, Trumpp A. PMID: 24127490; PMCID: PMC3804947.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    65. The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell. 2013 Mar 18; 23(3):376-89. Arteaga MF, Mikesch JH, Qiu J, Christensen J, Helin K, Kogan SC, Dong S, So CW. PMID: 23518351; PMCID: PMC6812572.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    66. Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations. Leukemia. 2013 Jul; 27(7):1570-3. Li M, Jones L, Gaillard C, Binnewies M, Ochoa R, Garcia E, Lam V, Wei G, Yang W, Lobe C, Hermiston M, Passegué E, Kogan SC. PMID: 23443342; PMCID: PMC3715751.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    67. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J Clin Invest. 2013 Jan; 123(1):335-9. Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K. PMID: 23221337; PMCID: PMC3533281.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    68. PML-RARa Deregulates an Unexpectedly Small Number of Genes in Pre-Leukemic Promyelocytes. Blood. 2012 Nov 16; 120(21):3526-3526. Gaillard GC, Tokuyasu TT, Passegue´ PE, Kogan KS. .
      View in: Publisher Site   Mentions:
    69. Evaluation of Patients with Bleeding Symptoms Using a Novel Perfusion Chamber Assay (PCA). Blood. 2012 Nov 16; 120(21):3295-3295. Gorman GM, Kogan KS, Huang HJ, Stephens SG. .
      View in: Publisher Site   Mentions:
    70. Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants. Blood. 2012 Nov 16; 120(21):141-141. Smith SC, Lasater LE, Mccreery MM, Lin LK, Stewart SW, Damon DL, Perl PA, Jeschke JG, Sugita SM, Carroll CM, Kogan KS, Shah SN. .
      View in: Publisher Site   Mentions:
    71. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice. Haematologica. 2013 Mar; 98(3):424-7. Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. PMID: 23144197; PMCID: PMC3659942.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    72. A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis. PLoS Genet. 2012; 8(11):e1003034. Bagley BN, Keane TM, Maklakova VI, Marshall JG, Lester RA, Cancel MM, Paulsen AR, Bendzick LE, Been RA, Kogan SC, Cormier RT, Kendziorski C, Adams DJ, Collier LS. PMID: 23133403; PMCID: PMC3486839.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    73. Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. Cancer Res. 2012 Dec 15; 72(24):6425-34. Choi G, Huang B, Pinarbasi E, Braunstein SE, Horvai AE, Kogan S, Bhatia S, Faddegon B, Nakamura JL. PMID: 23071067; PMCID: PMC3787120.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    74. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Blood. 2012 May 10; 119(19):4512-23. Bergerson RJ, Collier LS, Sarver AL, Been RA, Lugthart S, Diers MD, Zuber J, Rappaport AR, Nixon MJ, Silverstein KA, Fan D, Lamblin AF, Wolff L, Kersey JH, Delwel R, Lowe SW, O'Sullivan MG, Kogan SC, Adams DJ, Largaespada DA. PMID: 22427200; PMCID: PMC3362364.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    75. Heterozygous Germ Line Deletion of a 2Mb Interval in Mice That Models Loss of 7q22 in Human Myeloid Malignancies Results in Defective Hematopoietic Stem Cell Function Reminiscent of Premature Aging. Blood. 2011 Nov 18; 118(21):2340-2340. Wong WJ, Weinfurtner WK, Zhang ZY, Alzamora AP, Hwang HE, Kogan KS, Shannon SK. .
      View in: Publisher Site   Mentions:
    76. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 2011 Oct 15; 25(20):2125-36. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS, Kogan SC, Lowe SW. PMID: 21979375; PMCID: PMC3205583.
      View in: PubMed   Mentions: 447     Fields:    Translation:HumansAnimalsCells
    77. PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway. Autophagy. 2011 Oct; 7(10):1132-44. Huang Y, Hou JK, Chen TT, Zhao XY, Yan ZW, Zhang J, Yang J, Kogan SC, Chen GQ. PMID: 21673516; PMCID: PMC3210306.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    78. Abstract A37: A dominantly acting allele of murine Mcm4 causes chromosome instability and promotes leukemiogenesis. Cancer Genomics. 2011 Sep 15; a37-a37. Bagley BB, Maklakova MV, Kendziorski KC, Adams AD, Collier CL, Marshall MJ, Lester LR, Cancel CM, Bendzick BL, Keane KT, Kogan KS, Sullivan SR, Cormier CR. .
      View in: Publisher Site   Mentions:
    79. Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response. Sci Transl Med. 2011 Sep 14; 3(100):100ra90. Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M, Springer ML. PMID: 21918107; PMCID: PMC3350804.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    80. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011 Aug 03; 478(7370):524-8. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR. PMID: 21814200; PMCID: PMC3328300.
      View in: PubMed   Mentions: 1049     Fields:    Translation:HumansAnimalsCells
    81. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev. 2011 Aug 01; 25(15):1628-40. Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Fellman C, Taylor MJ, Weissenboeck M, Graeber TG, Kogan SC, Vakoc CR, Lowe SW. PMID: 21828272; PMCID: PMC3182026.
      View in: PubMed   Mentions: 167     Fields:    Translation:Animals
    82. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell. 2011 Apr 01; 145(1):145-58. Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miething C, Scuoppo C, Zuber J, Dickins RA, Kogan SC, Shroyer KR, Sordella R, Hannon GJ, Lowe SW. PMID: 21458673; PMCID: PMC3244080.
      View in: PubMed   Mentions: 189     Fields:    Translation:AnimalsCells
    83. Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. Genes Cancer. 2011 Feb; 2(2):160-5. Scaglioni PP, Cai LF, Majid SM, Yung TM, Socci ND, Kogan SC, Kopelovich L, Pandolfi PP. PMID: 21779489; PMCID: PMC3111249.
      View in: PubMed   Mentions: 1  
    84. Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. Cancer Res. 2011 Jan 01; 71(1):106-15. Nakamura JL, Phong C, Pinarbasi E, Kogan SC, Vandenberg S, Horvai AE, Faddegon BA, Fiedler D, Shokat K, Houseman BT, Chao R, Pieper RO, Shannon K. PMID: 21199799; PMCID: PMC3077533.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    85. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Blood. 2011 Feb 10; 117(6):2022-32. Li Q, Haigis KM, McDaniel A, Harding-Theobald E, Kogan SC, Akagi K, Wong JC, Braun BS, Wolff L, Jacks T, Shannon K. PMID: 21163920; PMCID: PMC3056645.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    86. Mutant BCL2 Co-Operates with CBFß/PEBP2ß-MYH11 to Promote Expansion of Leukemia Initiating Cells with a Predominantly Pro-Apoptotic Mechanism Via Recruitment of Ras-GTP In a Mouse Model of Progressive Acute Myeloid Leukemia. Blood. 2010 Nov 19; 116(21):1050-1050. Omidvar ON, Pogam PC, Beurlet BS, Noguera NM, Janin JA, Kogan KS, Weissman WI, Pla PM, Chomienne CC, Padua PR. .
      View in: Publisher Site   Mentions:
    87. ABT-737 Targets Leukemic Stem Cells In Mouse Models of Mutant NRASD12/hBCL-2- Mediated Acute Myeloid Leukemia Progression with Increased Survival. Blood. 2010 Nov 19; 116(21):3308-3308. Padua PR, Beurlet BS, Krief KP, Omidvar ON, Pogam PC, Auboeuf AD, de la Grange dP, Soulie SA, Janin JA, Noguera NM, Merlet MP, Sarda-Mantel SL, Fenaux FP, Konopleva KM, Andreeff AM, Tu TA, Yang YP, Fan FA, Kogan KS, Weissman WI, Felsher FD, Pla PM, West WR, Chomienne CC. .
      View in: Publisher Site   Mentions:
    88. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med. 2010 Nov 22; 207(12):2581-94. Jones L, Wei G, Sevcikova S, Phan V, Jain S, Shieh A, Wong JC, Li M, Dubansky J, Maunakea ML, Ochoa R, Zhu G, Tennant TR, Shannon KM, Lowe SW, Le Beau MM, Kogan SC. PMID: 21059853; PMCID: PMC2989761.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    89. PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia. Cancer Res. 2010 Nov 01; 70(21):8792-801. Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R. PMID: 20861188; PMCID: PMC3021794.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    90. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes Dev. 2010 Jul 01; 24(13):1389-402. Zhao Z, Zuber J, Diaz-Flores E, Lintault L, Kogan SC, Shannon K, Lowe SW. PMID: 20595231; PMCID: PMC2895198.
      View in: PubMed   Mentions: 96     Fields:    Translation:AnimalsCells
    91. Abstract 3427A: Focal fractionated irradiation induces specific malignancies in a dose-dependent manner in Nf1 mutant mice. Clinical Research. 2010 Apr 15; 3427a-3427a. Nakamura NJ, Phong PC, Pinarbasi PE, Kogan KS, Vandenberg VS, Horvai HA, Faddegon FB, Houseman HB, Pieper PR, Shannon SK. .
      View in: Publisher Site   Mentions:
    92. Medicine. Poisonous contacts. Science. 2010 Apr 09; 328(5975):184-5. Kogan SC. PMID: 20378808.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    93. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Blood. 2010 Jun 03; 115(22):4524-32. Wong JC, Zhang Y, Lieuw KH, Tran MT, Forgo E, Weinfurtner K, Alzamora P, Kogan SC, Akagi K, Wolff L, Le Beau MM, Killeen N, Shannon K. PMID: 20233966; PMCID: PMC2881500.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    94. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci U S A. 2010 Mar 16; 107(11):5106-11. Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K. PMID: 20194733; PMCID: PMC2841878.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    95. An Insertional Mutagenesis Screen for Genes That Cooperate with Mll-AF9 in Leukemogenesis. Blood. 2009 Nov 20; 114(22):3962-3962. Bergerson BR, Collier CL, Lugthart LS, Allaei AR, Nixon NM, Silverstein SK, Sarver SA, Fan FD, Lamblin LA, Wolff WL, Kersey KJ, O'Sullivan OM, Delwel DR, Kogan KS, Adams AD, Largaespada LD. .
      View in: Publisher Site   Mentions:
    96. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature. 2009 Sep 17; 461(7262):411-4. Lauchle JO, Kim D, Le DT, Akagi K, Crone M, Krisman K, Warner K, Bonifas JM, Li Q, Coakley KM, Diaz-Flores E, Gorman M, Przybranowski S, Tran M, Kogan SC, Roose JP, Copeland NG, Jenkins NA, Parada L, Wolff L, Sebolt-Leopold J, Shannon K. PMID: 19727076; PMCID: PMC4119783.
      View in: PubMed   Mentions: 82     Fields:    Translation:Animals
    97. Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 2009 Apr 01; 23(7):877-89. Zuber J, Radtke I, Pardee TS, Zhao Z, Rappaport AR, Luo W, McCurrach ME, Yang MM, Dolan ME, Kogan SC, Downing JR, Lowe SW. PMID: 19339691; PMCID: PMC2666344.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansAnimals
    98. Curing APL: differentiation or destruction? Cancer Cell. 2009 Jan 06; 15(1):7-8. Kogan SC. PMID: 19111876.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    99. Myc Drives Chromosomal Gain in Acute Myeloid Leukemia. Blood. 2008 Nov 16; 112(11):792-792. Jones JL, Sevcikova SS, Phan PV, Jain JS, Shieh SA, Dubansky DJ, Li LM, Maunakea MM, Zhu ZG, Tennant TT, Lowe LS, Le LM, Kogan KS. .
      View in: Publisher Site   Mentions:
    100. ABT-737 Targets Intrinsic Apoptosis during Cooperation of BCL-2 and Oncogenic NRAS in An in Vivo Progression Model of Myelodysplasia/Acute Myeloid Leukaemia. Blood. 2008 Nov 16; 112(11):848-848. Omidvar ON, Beurlet BS, Le Pogam LC, Janin JA, Leboeuf LC, Soulie SA, Setterblad SN, Noguera NM, Sarda-Mantel SL, Merlet MP, Pla PM, Kogan KS, Weissman WI, Konopleva KM, Bormann BW, Andreeff AM, Chomienne CC, Padua PR. .
      View in: Publisher Site   Mentions:
    101. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell. 2008 Oct 09; 3(4):416-28. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegué E, Sage J. PMID: 18940733; PMCID: PMC2646421.
      View in: PubMed   Mentions: 97     Fields:    Translation:AnimalsCells
    102. Fractionated Cranial Irradiation Induces a Distinctive Pattern of Second Malignant Neoplasms in Nf1 Mutant Mice. International Journal of Radiation Oncology • Biology • Physics. 2008 Sep 1; 72(1):s83. Nakamura NJ, Phong PC, Kogan KS, Vandenberg VS, Pieper PR, Shannon SK. .
      View in: Publisher Site   Mentions:
    103. mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci U S A. 2008 Aug 05; 105(31):10853-8. Mills JR, Hippo Y, Robert F, Chen SM, Malina A, Lin CJ, Trojahn U, Wendel HG, Charest A, Bronson RT, Kogan SC, Nadon R, Housman DE, Lowe SW, Pelletier J. PMID: 18664580; PMCID: PMC2504845.
      View in: PubMed   Mentions: 167     Fields:    Translation:AnimalsCells
    104. Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure. Mutagenesis. 2008 Sep; 23(5):341-6. Nagasubramanian R, Hansen RJ, Delaney SM, Cherian MM, Samson LD, Kogan SC, Dolan ME. PMID: 18477655; PMCID: PMC2527341.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    105. The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. J Hum Hypertens. 2008 Jul; 22(7):512-5. Kelley-Hedgepeth A, Peter I, Kip K, Montefusco M, Kogan S, Cox D, Ordovas J, Levy D, Reis S, Mendelsohn M, Housman D, Huggins G. PMID: 18418400; PMCID: PMC2659689.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    106. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res. 2007 Dec 15; 67(24):11657-67. Omidvar N, Kogan S, Beurlet S, le Pogam C, Janin A, West R, Noguera ME, Reboul M, Soulie A, Leboeuf C, Setterblad N, Felsher D, Lagasse E, Mohamedali A, Thomas NS, Fenaux P, Fontenay M, Pla M, Mufti GJ, Weissman I, Chomienne C, Padua RA. PMID: 18089795.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    107. Novel Mll-AF9 Cooperating Genes Identified in a Leukemogenesis Screen Using Retroviral Mutagenesis. Blood. 2007 Nov 16; 110(11):825-825. Bergerson BR, Collier CL, Allaei AR, Silverstein SK, Lamblin LA, Wolff WL, Kogan KS, Kersey KJ, Adams AD, Largaespada LD. .
      View in: Publisher Site   Mentions:
    108. Expressing N-RasG12D from the Endogenous Promoter Induces Myeloproliferative Disease (MPD) and Cooperates with Retroviral Insertional Mutagenesis (RIM) To Generate Acute Myeloid Leukemia (AML). Blood. 2007 Nov 16; 110(11):1616-1616. Li LQ, Haigis HK, McDaniel MA, Huang HB, Miller MM, Shieh SA, Kogan KS, Wolff WL, Jacks JT, Shannon SK. .
      View in: Publisher Site   Mentions:
    109. PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL. Cancer Biol Ther. 2007 Dec; 6(12):1967-77. Tabe Y, Konopleva M, Kondo Y, Contractor R, Tsao T, Konoplev S, Shi Y, Ling X, Watt JC, Tsutsumi-Ishii Y, Ohsaka A, Nagaoka I, Issa JP, Kogan SC, Andreeff M. PMID: 18075297.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    110. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood. 2007 Jul 15; 110(2):719-26. Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM. PMID: 17420284; PMCID: PMC1924479.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    111. Mouse models of acute promyelocytic leukemia. Curr Top Microbiol Immunol. 2007; 313:3-29. Kogan SC. PMID: 17217036.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    112. Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice. Leuk Res. 2007 Aug; 31(8):1131-4. Lee BD, Sevcikova S, Kogan SC. PMID: 17184839; PMCID: PMC2680761.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    113. Acute Promyelocytic Leukemia Stem Cell Derived from Leukemic Progenitor. Blood. 2006 Nov 16; 108(11):235-235. Rosen RG, Kogan KS. .
      View in: Publisher Site   Mentions:
    114. SU11657 Cooperates with Doxorubicin To Increase Survival of Leukemic Mice. Blood. 2006 Nov 16; 108(11):4572-4572. Sevcikova SS, Lee LB, Kogan KS. .
      View in: Publisher Site   Mentions:
    115. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. Blood. 2007 Feb 15; 109(4):1687-91. Kim A, Morgan K, Hasz DE, Wiesner SM, Lauchle JO, Geurts JL, Diers MD, Le DT, Kogan SC, Parada LF, Shannon K, Largaespada DA. PMID: 17090653; PMCID: PMC1794059.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    116. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res. 2006 Aug 01; 66(15):7639-46. Wendel HG, Malina A, Zhao Z, Zender L, Kogan SC, Cordon-Cardo C, Pelletier J, Lowe SW. PMID: 16885364; PMCID: PMC4586049.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCells
    117. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell. 2006 Jul 28; 126(2):415-26. Forsberg EC, Serwold T, Kogan S, Weissman IL, Passegué E. PMID: 16873070.
      View in: PubMed   Mentions: 94     Fields:    Translation:AnimalsCells
    118. CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities. Blood. 2006 Oct 01; 108(7):2416-9. Lee YJ, Jones LC, Timchenko NA, Perrotti D, Tenen DG, Kogan SC. PMID: 16788101; PMCID: PMC1895555.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    119. Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proc Natl Acad Sci U S A. 2006 May 09; 103(19):7444-9. Wendel HG, de Stanchina E, Cepero E, Ray S, Emig M, Fridman JS, Veach DR, Bornmann WG, Clarkson B, McCombie WR, Kogan SC, Hochhaus A, Lowe SW. PMID: 16651519; PMCID: PMC1455409.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    120. Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp Hematol. 2006 May; 34(5):631-41. Yin B, Kogan SC, Dickins RA, Lowe SW, Largaespada DA. PMID: 16647569.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    121. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene. 2006 Mar 23; 25(13):1974-9. Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. PMID: 16331271.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    122. Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia. J Biol Chem. 2006 Apr 21; 281(16):10745-51. Zhuang D, Qiu Y, Kogan SC, Dong F. PMID: 16500901.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    123. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell. 2006 Feb; 9(2):81-94. Sternsdorf T, Phan VT, Maunakea ML, Ocampo CB, Sohal J, Silletto A, Galimi F, Le Beau MM, Evans RM, Kogan SC. PMID: 16473276.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    124. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell. 2006 Jan; 9(1):57-68. Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP, Le Beau MM, Kogan SC, Castilla LH. PMID: 16413472.
      View in: PubMed   Mentions: 78     Fields:    Translation:AnimalsCells
    125. Investigation of Hematopoietic Stem Cell and Progenitor Populations: Implication for Cell Fate Determination and Lineage Commitment. Blood. 2005 Nov 16; 106(11):801-801. Passegue PE, Forsberg FC, Serwold ST, Kogan KS, Weissman WI. .
      View in: Publisher Site   Mentions:
    126. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. Br J Haematol. 2005 Nov; 131(4):495-507. Yamashita N, Osato M, Huang L, Yanagida M, Kogan SC, Iwasaki M, Nakamura T, Shigesada K, Asou N, Ito Y. PMID: 16281942.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    127. Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia. Nat Rev Cancer. 2005 10; 5(10):821-7. Lallemand-Breitenbach V, Zhu J, Kogan S, Chen Z, de Thé H. PMID: 16175176.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    128. Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell. 2005 Oct; 8(4):337-48. Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J, Borowsky A, Horvai A, Kogan SC, Bonifas J, Huey B, Jacks TE, Albertson DG, Shannon KM. PMID: 16226708.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    129. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood. 2006 Jan 15; 107(2):698-707. Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC, Chen GQ. PMID: 16166593.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    130. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities. J Pharmacol Exp Ther. 2005 Dec; 315(3):1247-55. Hansen RJ, Nagasubramanian R, Delaney SM, Cherian MM, Lin S, Kogan SC, Dolan ME. PMID: 16126841.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    131. Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation. Molecular and Cellular Biology. 2005 Jul 1; 25(13):5787-5787. Phan PV, Shultz SD, Truong TB, Blake BT, Brown BA, Gonda GT, Le Beau LM, Kogan KS. .
      View in: Publisher Site   Mentions:
    132. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell. 2005 Feb; 7(2):143-53. Zhu J, Zhou J, Peres L, Riaucoux F, Honoré N, Kogan S, de Thé H. PMID: 15710327.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    133. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J. 2005 Jan 26; 24(2):368-81. Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. PMID: 15635450; PMCID: PMC545811.
      View in: PubMed   Mentions: 40     Fields:    Translation:Animals
    134. O-14 A reversible two-step model ofMDS/preleukemia: Transgenic mice expressing inducible BCL2 and mutant NRAS. Leukemia Research. 2005 Jan 1; 29:s5. Padua PR, Omidvar ON, Kogan KS, Phan PT, West WR, Felsher FD, Weissmann WI, Thomas TS, Whittaker WJ, Janin JA, Pla PM, Muftis MG, Bishop BJ, Chomienne CC. .
      View in: Publisher Site   Mentions:
    135. Discovery of Genes Involved in Experimental Pre-Leukemia to Leukemia Transition in Mice Using Expression Arrays. Blood. 2004 Nov 16; 104(11):1109-1109. Entin EI, Kogan KS. .
      View in: Publisher Site   Mentions:
    136. Cbfb-MYH11 Induces Expansion of a Lin-Kit+Sca1- Abnormal Progenitor Compartment that Predisposes Acute Myeloid Leukemia in Mice. Blood. 2004 Nov 16; 104(11):543-543. Kuo KY, Heilman HS, Chen CA, Liu LP, Gernstein GR, Kogan KS, Castilla CL. .
      View in: Publisher Site   Mentions:
    137. Identification of Cooperating Genetic Alterations in RUNX Leukemia Using the Mouse Model for the Human Familial Leukemia, FPD/AML. Blood. 2004 Nov 16; 104(11):3383-3383. Osato OM, Yamashita YN, Yanagida YM, Huang HL, Kogan KS, Iwasaki IM, Nakamura NT, Shigesada SK, Asou AN, Ito IY. .
      View in: Publisher Site   Mentions:
    138. Increased DNA Damage and Error-Prone Repair in MPD/MDS Mice with Disease Progression: Key Indicators for Increased Genomic Instability. Blood. 2004 Nov 16; 104(11):200-200. Rassool RF, Gaymes GT, Brady BN, Lea LN, Pla PM, Phan PT, Kogan KS, Chomienne CC, Thomas TN, Mafti MG, Padua PR. .
      View in: Publisher Site   Mentions:
    139. Cooperative Pathways to Acute Myeloid Leukemia Include the Combining of Transcription Factor Alterations: PML-RARa Cooperates with SOX4. Blood. 2004 Nov 16; 104(11):3385-3385. Kogan KS, Maunakea MM, Himmel HK, Yin YB, Le Beau LM, Largaespada LD. .
      View in: Publisher Site   Mentions:
    140. Homodimerization of Retinoic Acid Receptor alpha through its Fusion Partners Underlies Pathogenesis of Acute Promyelocytic Leukemia. Blood. 2004 Nov 16; 104(11):546-546. Kogan KS, Phan PV, Sternsdorf ST, Maunakea MM, Sohal SJ, Silletto SA, Galimi GF, Evans ER. .
      View in: Publisher Site   Mentions:
    141. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood. 2005 Feb 15; 105(4):1456-66. Fischbach NA, Rozenfeld S, Shen W, Fong S, Chrobak D, Ginzinger D, Kogan SC, Radhakrishnan A, Le Beau MM, Largman C, Lawrence HJ. PMID: 15522959.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    142. Myeloid Malignancies. Mouse Models of Human Cancer. 2004 Oct 15. Kogan KS. .
      View in: Publisher Site   Mentions:
    143. Mouse models of human cancers (part 3). Comp Med. 2004 Jun; 54(3):258-70. Borowsky AD, Munn RJ, Galvez JJ, Cardiff RD, Ward JM, Morse HC, Kogan SC, Aldape KD, Louis DN, Bosenberg MW. PMID: 15253271.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    144. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004 Mar 18; 428(6980):332-7. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. PMID: 15029198.
      View in: PubMed   Mentions: 395     Fields:    Translation:AnimalsCells
    145. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood. 2004 Jun 01; 103(11):4243-50. Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM. PMID: 14982883.
      View in: PubMed   Mentions: 92     Fields:    Translation:AnimalsCells
    146. The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. Cancer Res. 2004 Jan 15; 64(2):581-9. Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, Evan GI. PMID: 14744772.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    147. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):597-602. Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE, Shannon KM. PMID: 14699048; PMCID: PMC327193.
      View in: PubMed   Mentions: 153     Fields:    Translation:AnimalsCells
    148. PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med. 2003 Nov; 9(11):1413-7. Padua RA, Larghero J, Robin M, le Pogam C, Schlageter MH, Muszlak S, Fric J, West R, Rousselot P, Phan TH, Mudde L, Teisserenc H, Carpentier AF, Kogan S, Degos L, Pla M, Bishop JM, Stevenson F, Charron D, Chomienne C. PMID: 14566333.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    149. A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis. Cancer Res. 2003 Sep 01; 63(17):5257-65. Hansen LA, Brown D, Virador V, Tanaka T, Andreola F, Strain K, Dancheck B, Riley R, Arbeit JM, De Luca LM, Kogan S, Yuspa SH. PMID: 14500356.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    150. Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation. Mol Cell Biol. 2003 Jul; 23(13):4573-85. Phan VT, Shultz DB, Truong BT, Blake TJ, Brown AL, Gonda TJ, Le Beau MM, Kogan SC. PMID: 12808098; PMCID: PMC164846.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    151. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia. Blood. 2003 Aug 01; 102(3):1072-4. Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J, Kogan SC. PMID: 12689927.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    152. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood. 2003 Apr 15; 101(8):3188-97. Sohal J, Phan VT, Chan PV, Davis EM, Patel B, Kelly LM, Abrams TJ, O'Farrell AM, Gilliland DG, Le Beau MM, Kogan SC. PMID: 12515727.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    153. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002 Jul 01; 100(1):238-45. Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC, Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium. PMID: 12070033.
      View in: PubMed   Mentions: 220     Fields:    Translation:HumansAnimals
    154. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood. 2002 Apr 15; 99(8):2985-91. Le Beau MM, Bitts S, Davis EM, Kogan SC. PMID: 11929790.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    155. Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia. J Virol. 2001 Oct; 75(19):9427-34. Blaydes SM, Kogan SC, Truong BT, Gilbert DJ, Jenkins NA, Copeland NG, Largaespada DA, Brannan CI. PMID: 11533205; PMCID: PMC114510.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    156. Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi. Cancer Res. 2001 Apr 15; 61(8):3472-9. Gum JR, Hicks JW, Gillespie AM, Rius JL, Treseler PA, Kogan SC, Carlson EJ, Epstein CJ, Kim YS. PMID: 11309310.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    157. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. J Exp Med. 2001 Feb 19; 193(4):531-43. Kogan SC, Brown DE, Shultz DB, Truong BT, Lallemand-Breitenbach V, Guillemin MC, Lagasse E, Weissman IL, Bishop JM. PMID: 11181704; PMCID: PMC2195904.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    158. Patient and clinician vocabulary: how different are they? Stud Health Technol Inform. 2001; 84(Pt 1):399-403. Zeng Q, Kogan S, Ash N, Greenes RA. PMID: 11604772.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    159. Acute promyelocytic leukemia: a view from a mouse. Blood Cells Mol Dis. 2000 Dec; 26(6):620-5. Kogan SC. PMID: 11358354.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    160. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood. 2000 Mar 01; 95(5):1541-50. Kogan SC, Hong SH, Shultz DB, Privalsky ML, Bishop JM. PMID: 10688806.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    161. Acute promyelocytic leukemia: from treatment to genetics and back. Oncogene. 1999 Sep 20; 18(38):5261-7. Kogan SC, Bishop JM. PMID: 10498878.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    162. Images in clinical medicine. Indinavir crystalluria. N Engl J Med. 1999 Apr 29; 340(17):1329. Tsao JW, Kogan SC. PMID: 10219068.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    163. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med. 1999 Apr 05; 189(7):1043-52. Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC, Bishop JM, de Thé H. PMID: 10190895; PMCID: PMC2193002.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimalsCells
    164. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11863-8. Kogan SC, Lagasse E, Atwater S, Bae SC, Weissman I, Ito Y, Bishop JM. PMID: 9751756; PMCID: PMC21731.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    165. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1997 Mar 18; 94(6):2551-6. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM. PMID: 9122233; PMCID: PMC20126.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansAnimalsCells
    166. 6 The effect of fractionated radiotherapy in glioblastoma depends on P53 function. International Journal of Radiation Oncology • Biology • Physics. 1996 Jan 1; 36(1):161. Haas-Kogan HD, Kogan KS, Yount YG, Hsu HJ, Dewey DW, Phillips PT, Israel IM. .
      View in: Publisher Site   Mentions:
    167. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 1995 Feb 01; 14(3):461-72. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, Israel MA. PMID: 7859736; PMCID: PMC398104.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    168. 157 P53-dependent G1 arrest and P53-independent apoptosis influence the radiobiologic response of glioblastoma. International Journal of Radiation Oncology • Biology • Physics. 1995 Jan 1; 32:219. Haas-Kogan HD, Yount YG, Haas HM, Levi LD, Kogan KS, Hu HL, Vidair VC, Deen DD, Dewey DW, Israel IM. .
      View in: Publisher Site   Mentions:
    169. Genitourinary malformations associated with agenesis of the corpus callosum. J Urol. 1993 May; 149(5):1119-21. Franco I, Kogan S, Fisher J, Rifkinson-Mann S, Reda E, Levitt S, Roseman B. PMID: 8483226.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    170. Amino acid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild and moderately severe hemophilia A. Hum Mutat. 1992; 1(3):248-57. Diamond C, Kogan S, Levinson B, Gitschier J. PMID: 1301932.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    171. Genetic basis of hemophilia A. Thromb Haemost. 1991 Jul 12; 66(1):37-9. Gitschier J, Kogan S, Diamond C, Levinson B. PMID: 1926049.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    172. Mutations and a polymorphism in the factor VIII gene discovered by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2092-6. Kogan S, Gitschier J. PMID: 2107542; PMCID: PMC53632.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    173. 35 GENETIC PREDICTION OF HEMOPHILIA A. PCR Protocols. 1990 Jan 1; 288-299. Kogan KS, Gitschier GJ. .
      View in: Publisher Site   Mentions:
    174. Accurate prenatal diagnosis with novel polymerase chain reaction primers in a family with sporadic hemophilia A. Obstet Gynecol. 1989 Sep; 74(3 Pt 1):414-7. Sarkar G, Evans MI, Kogan S, Lusher J, Sommer SS. PMID: 2569705.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    175. Functional dissection and sequence of yeast HAP1 activator. Cell. 1989 Jan 27; 56(2):291-301. Pfeifer K, Kim KS, Kogan S, Guarente L. PMID: 2643482.
      View in: PubMed   Mentions: 128     Fields:    Translation:AnimalsCells
    176. Mutations of factor VIII cleavage sites in hemophilia A. Blood. 1988 Sep; 72(3):1022-8. Gitschier J, Kogan S, Levinson B, Tuddenham EG. PMID: 3137981.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    177. Mutations of factor VIII cleavage sites in hemophilia A. Blood. 1988 Sep 1; 72(3):1022-1028. Gitschier GJ, Kogan KS, Levinson LB, Tuddenham TE. .
      View in: Publisher Site   Mentions:
    178. An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences. Obstetrical & Gynecological Survey. 1988 Apr 1; 43(4):236-238. KOGAN KS, DOHERTY DM, GITSCHIER GJ. .
      View in: Publisher Site   Mentions:
    179. An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences. Obstetrical & Gynecological Survey. 1988 Apr 1; 43(4):236-238. KOGAN KS, DOHERTY DM, GITSCHIER GJ. .
      View in: Publisher Site   Mentions:
    180. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med. 1987 Oct 15; 317(16):985-90. Kogan SC, Doherty M, Gitschier J. PMID: 3657865.
      View in: PubMed   Mentions: 211     Fields:    Translation:HumansCells
    Scott's Networks
    Concepts (620)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (85)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.